Cargando…
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy
Although there has been significant progress in prevention and treatment of cervical cancer, this malignancy is still a leading cause of cancer death for women. Anti-angiogenesis and immunotherapy approaches have been providing survival benefits, however, response rates and durability of response ne...
Autores principales: | Roszik, Jason, Ring, Kari L., Wani, Khalida M., Lazar, Alexander J., Yemelyanova, Anna V., Soliman, Pamela T., Frumovitz, Michael, Jazaeri, Amir A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156434/ https://www.ncbi.nlm.nih.gov/pubmed/30283446 http://dx.doi.org/10.3389/fimmu.2018.02102 |
Ejemplares similares
-
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
por: Qin, Yong, et al.
Publicado: (2017) -
Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018) -
mTOR at the Transmitting and Receiving Ends in Tumor Immunity
por: Guri, Yakir, et al.
Publicado: (2018) -
Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation
por: Lyons, Yasmin A., et al.
Publicado: (2014) -
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
por: Qin, Yong, et al.
Publicado: (2020)